T.C.M. 3600 Creatine Malate OstroVit 180 capsules

OstroVit
€22.99 €14.99
T.C.M. 3600 Creatine Malate OstroVit OstroVit Creatine Malate (TCM) is a premium creatine supplement designed to enhance physical performance, muscle power, and recovery. It combines three creatine molecules with one malic acid molecule, improving absorption, stability, and effectiveness compared to traditional monohydrate. Regular use helps increase ATP production, resulting in...

T.C.M. 3600 Creatine Malate OstroVit

OstroVit Creatine Malate (TCM) is a premium creatine supplement designed to enhance physical performance, muscle power, and recovery. It combines three creatine molecules with one malic acid molecule, improving absorption, stability, and effectiveness compared to traditional monohydrate.

Regular use helps increase ATP production, resulting in higher training intensity, faster recovery, and greater muscle strength.

TCM Creatine Malate OstroVit

  • Increases strength and training performance
  • Enhances recovery and endurance
  • No water retention
  • More stable than monohydrate
  • Supports ATP regeneration and muscle growth

Ingredients & effects T.C.M. 3600 Creatine Malate OstroVit

  • Tri-Creatine Malate (TCM) – stable and easily absorbed form of creatine.
  • Capsule shell – protects the active ingredient and ensures convenience.

Effects:

  • Boosts muscle power and strength
  • Enhances endurance and recovery
  • Supports lean muscle growth
  • No bloating or water retention
  • Highly soluble and stable form

Who is it for?

  • Strength & endurance athletes
  • Gym-goers aiming for muscle growth
  • Individuals seeking faster recovery
  • Those wanting pure, efficient creatine support

How to use

  • Take 4 capsules daily (2 before and 2 after training).
  • On rest days, take 4 capsules after breakfast.
  • Use consistently for 6–8 weeks.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
Have Questions?Ask An Expert
MEGAPUMP uses cookies to understand how you use our site and to improve your experience. By continuing to use our site, you consent to the use of cookies.
Please confirm your subscription with following email
This email has been registered